Skip to main content

Table 1 Percentages of magnetosomes smaller than 30 nm, percentages of magnetosomes larger than 30 nm, and dominant magnetosome sizes within the whole magnetosome size distribution for untreated magnetosomes, magnetosomes internalized in U87-Luc cells, magnetosomes administered to intracranial U87-Luc tumors without magnetic treatment, or magnetosomes injected to intracranial U87-Luc tumors followed by 15 magnetic sessions during which an AMF of 198 kHz and 27 mT is applied during 30 min

From: Biodegraded magnetosomes with reduced size and heating power maintain a persistent activity against intracranial U87-Luc mouse GBM tumors

 

Percentage of magnetosomes smaller than 30 nm

Percentage of magnetosomes larger than 30 nm

Dominant magnetosomes size DMS (nm)

Untreated magnetosomes

42

58

40

Internalized magnetosomes (in vitro)

92.5

7.5

11

Magnetosomes administered in U87-Luc tumors and kept in the tumors for 30 days without AMF application

23.5

76.5

43

Magnetosomes administered in intracranial U87-Luc tumors followed by 15 MS

64

36

29